Elsevier

Life Sciences

Volume 54, Issue 25, 1994, Pages PL463-PL469
Life Sciences

Pharmacology letter
Identification of a human delta opioid receptor: Cloning and expression

https://doi.org/10.1016/0024-3205(94)90138-4Get rights and content

Abstract

The δ opioid receptor is an important target for analgesic drug development. This report describes the identification of δ opioid receptor clones from human cDNA libraries and the preparation of a human δ receptor cDNA in the pcDNA3 expression vector for transfection studies. The cDNA encodes a 372 amino acid protein that has 93% amino acid identity to mouse and rat δ receptors. COS-7 cells transfected with this clone express over 1.0 pmole receptor/mg protein when measured by saturation binding with [3H]naltrindole. The δ receptor selective ligands NTB, BNTX, [4′-Cl-Phe4]DPDPE and [D-Ala2, Glu4]deltorphin all have Ki values under 10 nM while the affinities of the μ and κ opioid receptor ligands CTAP and U-69593, respectively, are over 4.0 μM. Agonists show binding to multiple affinity states of the receptor consistent with the presence of G-protein coupled and uncoupled forms of the expressed receptor. The 8-fold higher affinity of NTB relative to BNTX suggests that the human δ receptor is of the δ2 subtype.

References (25)

  • N.A. Sharif et al.

    Peptides

    (1989)
  • A. Mattia et al.

    Eur. J. Pharmacol.

    (1991)
  • L.K. Vaughn et al.

    Eur. J. Pharmacol.

    (1990)
  • M. Sofuoglu et al.

    Eur. J. Pharmacol.

    (1992)
  • M. Sofuoglu et al.

    Life Sci.

    (1993)
  • K. Fukuda et al.

    FEBS Lett.

    (1993)
  • M. Minami et al.

    FEBS Lett.

    (1993)
  • J.-B. Wang et al.

    FEBS Lett.

    (1994)
  • K.-J. Chang et al.

    Biochim. Biophys. Acta

    (1975)
  • H. Kong et al.

    J. Biol. Chem.

    (1993)
  • J.A. Lord et al.

    Nature (London)

    (1977)
  • R.J. Knapp et al.
  • Cited by (132)

    • Targeting opioid dysregulation in depression for the development of novel therapeutics

      2019, Pharmacology and Therapeutics
      Citation Excerpt :

      Initially isolated from mouse vas deferens (Lord, Waterfield, Hughes, & Kosterlitz, 1977), the DOR was the first opioid receptor to be sequenced (Evans, Keith Jr., Morrison, Magendzo, & Edwards, 1992; Kieffer, Befort, Gaveriaux-Ruff, & Hirth, 1992). This 372 amino acid, 7 transmembrane GPCR (Kieffer et al., 1992; Knapp et al., 1994; Quock et al., 1999; Simonin et al., 1994) has high binding affinity for β-endorphin and leu-enkephalin (Evans et al., 1992; Kieffer et al., 1992). Brain regions in rats that exhibited high Oprd1 mRNA expression included the frontal cortex, hippocampus, NAc and amygdalar complex (Fig. 2), regions of interest for depression and anxiety, (Mansour et al., 1987).

    • Bioinformatics and Evolution of Vertebrate Nociceptin and Opioid Receptors

      2015, Vitamins and Hormones
      Citation Excerpt :

      The ultimate discovery and isolation of the cDNA for the mouse delta-opioid receptor (mDOR1) from the labs of Evans in the United States and Kieffer in France in 1992 (Evans, Keith, Morrison, Magendzo, & Edwards, 1992; Kieffer, Befort, Gaveriaux-Ruff, & Hirth, 1992) for the first time linked an opioid receptor sequence to a pharmacologically defined opioid receptor. Once the mDOR cDNA sequence was known, homology cloning led to the identification of receptor sequences for numerous rodent, monkey, and the human opioid receptors, hMOR (Wang, Johnson, Persico, et al., 1994), hDOR (Knapp et al., 1994; Simonin et al., 1994), and hKOR (Mansson, Bare, & Yang, 1994; Simonin et al., 1995; Zhu et al., 1995). At the same time, cloning studies revealed another “opioid receptor-like” (ORL) sequence from numerous labs that was similar to an opioid receptor but did not look like one from pharmacological studies (Bunzow et al., 1994; Chen et al., 1994; Fukuda et al., 1994; Lachowicz, Shen, Monsma, & Sibley, 1995; Mollereau et al., 1994; Wang, Johnson, Imai, et al., 1994; Wick et al., 1994).

    • A comprehensive study on the putative δ-opioid receptor (sub)types using the highly selective δ-antagonist, Tyr-Tic-(2S,3R)-β-MePhe-Phe- OH

      2011, Neurochemistry International
      Citation Excerpt :

      However, the pharmacologically defined subtypes have not been identified at a molecular level to date (Allouche et al., 2000; Zaki et al., 1996). Only one δ-opioid receptor gene (DOR-1) has been cloned from the amphibian Rana pipiens (Stevens et al., 2007), mouse (Zhu et al., 1999), rat (Fukuda et al., 1993) and human (Knapp et al., 1994) brain so far. It has been shown that the DOR-1 gene encodes both δ1 and δ2 subtypes (Zhu et al., 1999).

    • Synthesis of 6,14-epoxymorphinan derivatives and their pharmacologies

      2011, Bioorganic and Medicinal Chemistry
      Citation Excerpt :

      Three types of opioid receptors (μ, δ, κ) are now well established not only by pharmacological studies but also by molecular biological characterizations.1–4

    View all citing articles on Scopus
    View full text